Germany – Pharmaceutical products – Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit der Wirkstoffkombination aus Oxycodon und Naloxon (ATC-Code: N02AA55).

Conclusion of a non-exclusive discount contract under § 130a Para. 8 SGB V for medicinal products with the active substance combination of Oxycodon and Naloxon (ATC Code: N02AA55) within the period from 01.04.2026 to 31.03.2028 with the possibility of concluding the contract at any time during the term (“open-house model”).